CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-01 | Rosenthal Arnon Chief Executive Officer | Grant or award | +610,500 | 2,559,246 | ||
| 2024-10-01 | Romano Gary Chief Medical Officer | Grant or award | +184,380 | 364,175 | ||
| 2024-09-03 | GRASSO MARC Chief Financial Officer | Sale | −7,297 | $4.88 | $36K | 130,740 |
| 2024-09-03 | Rosenthal Arnon Chief Executive Officer | Sale | −26,499 | $4.88 | $129K | 1,948,746 |
| 2024-09-03 | Kenkare-Mitra Sara President and Head of R&D | Sale | −13,926 | $4.88 | $68K | 291,715 |
| 2024-09-03 | Romano Gary Chief Medical Officer | Sale | −8,478 | $4.88 | $41K | 179,795 |
| 2024-08-22 | SCHELLER RICHARD H Director | Sale | −44,250 | $5.16 | $228K | 35,000 |
| 2024-08-12 | Hammond Paula Director | Sale 10b5-1 | −10,500 | $5.06 | $53K | 60,209 |
| 2024-08-12 | Yaffe Kristine Director | Sale 10b5-1 | −5,000 | $5.06 | $25K | 67,709 |
| 2024-08-02 | SCHELLER RICHARD H Director | Grant or award | +15,833 | 50,833 | ||
| 2024-06-12 | LAVIGNE LOUIS J JR Director | Grant or award | +35,000 | 70,709 | ||
| 2024-06-12 | Yaffe Kristine Director | Grant or award | +35,000 | 72,709 | ||
| 2024-06-12 | GAROFALO ELIZABETH A. Director | Grant or award | +35,000 | 61,250 | ||
| 2024-06-12 | SCHELLER RICHARD H Director | Grant or award | +35,000 | 79,250 | ||
| 2024-06-12 | Wehner David M. Director | Grant or award | +35,000 | 115,330 | ||
| 2024-06-12 | Hammond Paula Director | Grant or award | +35,000 | 70,709 | ||
| 2024-06-03 | Rosenthal Arnon Chief Executive Officer | Sale | −25,135 | $4.80 | $121K | 1,975,245 |
| 2024-06-03 | Romano Gary Chief Medical Officer | Sale | −8,040 | $4.80 | $39K | 188,273 |
| 2024-06-03 | Kenkare-Mitra Sara President and Head of R&D | Sale | −13,206 | $4.80 | $63K | 305,641 |
| 2024-06-03 | GRASSO MARC Chief Financial Officer | Sale | −6,920 | $4.80 | $33K | 138,037 |
Page 7 of 23 · 454 trades